Article and Video CATEGORIES

Cancer Journey

Search By

Buddy is a strategic thought leader in new media technologies with 16+ years of digital content strategy experience. He has written and spoken extensively about healthcare marketing, social networks, marketing storytelling, web technologies and multimedia. He is the author of five mass market books on content, creative techniques, and process. He launched and maintained award-winning health information websites and was one of the driving forces behind placing the first pharmaceutical brand on a social network.

Dr. Jack West – Social Media in Healthcare
Author
Buddy Scalera, Board Member
Image

Buddy Scalera is a podcaster and Senior Director of Content Strategy in Global Health Science at the Medicines Company, and has been a member of the GRACE board of directors since 2011.   We are thankful to Buddy for his ongoing input to GRACE, and allowing us to share this interview with GRACE founder and president Jack West, MD.  


Recently Dr. Jack West made a special guest appearance on RxDM Storycast, with Buddy Scalera.  In this interview on the RX Digital Marketing Podcast, Dr. West discusses GRACE and topics related to storytelling in healthcare, the role of social media in healthcare, and the ways that the pharmaceutical industry can work effectively with non-government organizations.  

The full one-hour audio podcast and full transcript are available for free at the RXDigitalMarketing.com website, available here, or clicking the image below.

 “I think that oncologists and physicians, in general, have become enamored of statistics and evidence-based medicine, and of course that is really, has been in many ways, a benefit in the sophisticated way we think about treating patients,” explains Dr. West in the podcast, “but lost is the fact that everybody’s brain is really equipped best to think about narratives, about stories.”


The RX Digital Marketing podcast covers a wide range of topics, including ways that patients and professionals leverage social media for support. Dr. West spoke about early social networks during his TEDx talk in 2011. Buddy Scalera and Dr. West review key points from that presentation, as well. Dr. West’s TEDx talk can be viewed here

About Buddy Scalera

Senior Director, Content Strategy
Global Health Science, The Medicines Company

Buddy is a strategic thought leader in new media technologies with 16+ years of digital content strategy experience. He has written and spoken extensively about healthcare marketing, social networks, marketing storytelling, web technologies and multimedia. He is the author of five mass market books on content, creative techniques, and process. He launched and maintained award-winning health information websites and was one of the driving forces behind placing the first pharmaceutical brand on a social network. At The Medicines Company, Buddy is the Senior Director of Content Strategy in the Global Health Sciences division. 

Twitter: @BuddyScalera

Website: BuddyScalera.com

Video Language

Next Previous link

Previous PostNext Post

Related Content

Image
Amy Whitecotton Patient Perspectives
Video
Amy’s story is shared as part of the Patient Perspectives - Clinical Trials Experiences Storytelling Program
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on